United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read General business news Ester Industries (NSE: ESTER) rides polymer momentum despite Q2 FY26 net loss Ester’s Q2 FY26 results show specialty polymers gaining ground amid film margin pressure. Find out how ELITe and global tie-ups could reshape its future. bySrinathNovember 17, 2025